Posted inPress Releases
GSK Gains Regulatory Momentum for Hepatitis B Treatment as Jemperli Wins FDA Priority Review
GSK has received two important regulatory updates for its medicines targeting chronic hepatitis B and locally advanced rectal cancer, giving the pharmaceutical company fresh momentum across its infectious disease and…









